Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
HYDROGEN PEROXIDE
(2017)
Small molecule
Unknown
TOPICAL
Approved
Gingivitis; Infections; Keratosis, Seborrheic; Pharyngitis
HYDROGEN PEROXIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
BBX060AN9V
Molecule Type:
Small molecule
Molecular Formula:
H2O2
Molecular Weight:
34.01
AlogP:
0.02
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
PITAVASTATIN SODIUM
(2017)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
PITAVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
2017
UNII:
29556RBN9P
Molecule Type:
Small molecule
Molecular Formula:
C25H23FNNaO4
Molecular Weight:
443.45
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DELAFLOXACIN
(2017)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
DELAFLOXACIN
×
Maximum Phase:
4
First Approval:
2017
UNII:
6315412YVF
Molecule Type:
Small molecule
Molecular Formula:
C18H12ClF3N4O4
Molecular Weight:
440.77
AlogP:
1.92
PSA:
121.68
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VABORBACTAM
(2017)
Small molecule
Carbepenem-hydrolyzing beta-lactamase KPC inhibitor
Unknown
Approved
Urinary Tract Infections
VABORBACTAM
×
Maximum Phase:
4
First Approval:
2017
UNII:
1C75676F8V
Molecule Type:
Small molecule
Molecular Formula:
C12H16BNO5S
Molecular Weight:
297.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NIRAPARIB TOSYLATE
(2017)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
ORAL
Approved
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
NIRAPARIB TOSYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
75KE12AY9U
Molecule Type:
Small molecule
Molecular Formula:
C26H30N4O5S
Molecular Weight:
510.62
AlogP:
2.59
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BRIGATINIB
(2017)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
BRIGATINIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
HYW8DB273J
Molecule Type:
Small molecule
Molecular Formula:
C29H39ClN7O2P
Molecular Weight:
584.11
AlogP:
5.09
PSA:
85.86
HBD:
2.0
HBA:
#RotB:
8.0
Source:
NETARSUDIL DIMESYLATE
(2017)
Small molecule
Rho-associated protein kinase inhibitor
OPHTHALMIC
Approved
Glaucoma, Open-Angle; Ocular Hypertension
NETARSUDIL DIMESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
VL756B1K0U
Molecule Type:
Small molecule
Molecular Formula:
C30H35N3O9S2
Molecular Weight:
645.76
AlogP:
4.89
PSA:
94.31
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RIBOCICLIB SUCCINATE
(2017)
Small molecule
Cyclin-dependent kinase 4 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
RIBOCICLIB SUCCINATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
BG7HLX2919
Molecule Type:
Small molecule
Molecular Formula:
C27H36N8O5
Molecular Weight:
552.64
AlogP:
2.8
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LATANOPROSTENE BUNOD
(2017)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
LATANOPROSTENE BUNOD
×
Maximum Phase:
4
First Approval:
2017
UNII:
I6393O0922
Molecule Type:
Small molecule
Molecular Formula:
C27H41NO8
Molecular Weight:
507.62
AlogP:
3.77
PSA:
139.36
HBD:
3.0
HBA:
#RotB:
18.0
Source:
EDARAVONE
(2017)
Small molecule
Unknown
INTRAVENOUS
Approved
Amyotrophic Lateral Sclerosis
EDARAVONE
×
Maximum Phase:
4
First Approval:
2017
UNII:
S798V6YJRP
Molecule Type:
Small molecule
Molecular Formula:
C10H10N2O
Molecular Weight:
174.2
AlogP:
1.8
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
1.0
Source:
TELOTRISTAT ETIPRATE
(2017)
Small molecule
Tryptophan 5-hydroxylase inhibitor
Unknown
Approved
Diarrhea
TELOTRISTAT ETIPRATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
3T25U84H4U
Molecule Type:
Small molecule
Molecular Formula:
C36H35ClF3N7O6
Molecular Weight:
754.17
AlogP:
4.99
PSA:
131.17
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ENASIDENIB MESYLATE
(2017)
Small molecule
Isocitrate dehydrogenase [NADP], mitochondrial inhibitor
ORAL
Approved
Leukemia, Myeloid, Acute
ENASIDENIB MESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
UF6PC17XAV
Molecule Type:
Small molecule
Molecular Formula:
C20H21F6N7O4S
Molecular Weight:
569.49
AlogP:
4.29
PSA:
108.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
COPANLISIB
(2017)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
Unknown
Approved
Neoplasms
COPANLISIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
WI6V529FZ9
Molecule Type:
Small molecule
Molecular Formula:
C23H28N8O4
Molecular Weight:
480.53
AlogP:
0.66
PSA:
139.79
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NETARSUDIL
(2017)
Small molecule
Unknown
Unknown
Approved
Glaucoma
NETARSUDIL
×
Maximum Phase:
4
First Approval:
2017
UNII:
W6I5QDT7QI
Molecule Type:
Small molecule
Molecular Formula:
C28H27N3O3
Molecular Weight:
453.54
AlogP:
4.89
PSA:
94.31
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NALDEMEDINE TOSYLATE
(2017)
Small molecule
Mu opioid receptor antagonist
ORAL
Approved
Cancer Pain; Constipation
NALDEMEDINE TOSYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
V1N8F1RVVO
Molecule Type:
Small molecule
Molecular Formula:
C39H42N4O9S
Molecular Weight:
742.85
AlogP:
3.48
PSA:
141.18
HBD:
4.0
HBA:
#RotB:
6.0
Source:
RIBOCICLIB
(2017)
Small molecule
Cyclin-dependent kinase 4 inhibitor
Unknown
Approved
Unknown
RIBOCICLIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
TK8ERE8P56
Molecule Type:
Small molecule
Molecular Formula:
C23H30N8O
Molecular Weight:
434.55
AlogP:
2.8
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
5.0
Source:
COCAINE HYDROCHLORIDE
(2017)
Small molecule
Sodium channel alpha subunit blocker
NASAL
Approved
Anesthesia
COCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
XH8T8T6WZH
Molecule Type:
Small molecule
Molecular Formula:
C17H22ClNO4
Molecular Weight:
339.82
AlogP:
1.87
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PIBRENTASVIR
(2017)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C, Chronic
PIBRENTASVIR
×
Maximum Phase:
4
First Approval:
2017
UNII:
2WU922TK3L
Molecule Type:
Small molecule
Molecular Formula:
C57H65F5N10O8
Molecular Weight:
1113.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NALDEMEDINE
(2017)
Small molecule
Mu opioid receptor antagonist
Unknown
Approved
Constipation
NALDEMEDINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
03KSI6WLXH
Molecule Type:
Small molecule
Molecular Formula:
C32H34N4O6
Molecular Weight:
570.65
AlogP:
3.48
PSA:
141.18
HBD:
4.0
HBA:
#RotB:
6.0
Source:
BENZNIDAZOLE
(2017)
Small molecule
Unknown
ORAL
Approved
Chagas Disease; Leishmaniasis; Trypanosomiasis
BENZNIDAZOLE
×
Maximum Phase:
4
First Approval:
2017
UNII:
YC42NRJ1ZD
Molecule Type:
Small molecule
Molecular Formula:
C12H12N4O3
Molecular Weight:
260.25
AlogP:
1.11
PSA:
90.06
HBD:
1.0
HBA:
#RotB:
5.0
Source:
VALBENAZINE
(2017)
Small molecule
Synaptic vesicular amine transporter inhibitor
Unknown
Approved
Unknown
VALBENAZINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
54K37P50KH
Molecule Type:
Small molecule
Molecular Formula:
C24H38N2O4
Molecular Weight:
418.58
AlogP:
3.56
PSA:
74.02
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NIRAPARIB
(2017)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Approved
Neoplasms
NIRAPARIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
HMC2H89N35
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
2.59
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BICTEGRAVIR
(2018)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
Unknown
Approved
Unknown
BICTEGRAVIR
×
Maximum Phase:
4
First Approval:
2018
UNII:
8GB79LOJ07
Molecule Type:
Small molecule
Molecular Formula:
C21H18F3N3O5
Molecular Weight:
449.39
AlogP:
1.63
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AVATROMBOPAG MALEATE
(2018)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Liver Diseases; Thrombocytopenia
AVATROMBOPAG MALEATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
GDW7M2P1IS
Molecule Type:
Small molecule
Molecular Formula:
C33H38Cl2N6O7S2
Molecular Weight:
765.74
AlogP:
6.58
PSA:
101.9
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PRUCALOPRIDE SUCCINATE
(2018)
Small molecule
Serotonin 4 (5-HT4) receptor agonist
ORAL
Approved
Constipation
PRUCALOPRIDE SUCCINATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
4V2G75E1CK
Molecule Type:
Small molecule
Molecular Formula:
C22H32ClN3O7
Molecular Weight:
485.97
AlogP:
2.09
PSA:
76.82
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BENZHYDROCODONE
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
BENZHYDROCODONE
×
Maximum Phase:
4
First Approval:
2018
UNII:
75MS0AAZ9I
Molecule Type:
Small molecule
Molecular Formula:
C25H25NO4
Molecular Weight:
403.48
AlogP:
3.72
PSA:
48.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LAROTRECTINIB SULFATE
(2018)
Small molecule
Neurotrophic tyrosine kinase receptor inhibitor
ORAL
Approved
Neoplasm Metastasis; Neoplasms
LAROTRECTINIB SULFATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
RDF76R62ID
Molecule Type:
Small molecule
Molecular Formula:
C21H24F2N6O6S
Molecular Weight:
526.52
AlogP:
2.95
PSA:
86.0
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TECOVIRIMAT
(2018)
Small molecule
Envelope phospholipase F13 (p37) inhibitor
Unknown
Approved
Smallpox; Virus Diseases
TECOVIRIMAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
F925RR824R
Molecule Type:
Small molecule
Molecular Formula:
C19H15F3N2O3
Molecular Weight:
376.33
AlogP:
2.4
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BINIMETINIB
(2018)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
ORAL
Approved
Melanoma; Neoplasms
BINIMETINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
181R97MR71
Molecule Type:
Small molecule
Molecular Formula:
C17H15BrF2N4O3
Molecular Weight:
441.23
AlogP:
3.01
PSA:
88.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
IOBENGUANE I 131
(2018)
Small molecule
Norepinephrine transporter substrate
Unknown
Approved
Neuroblastoma; Paraganglioma; Pheochromocytoma
IOBENGUANE I 131
×
Maximum Phase:
4
First Approval:
2018
UNII:
Q461L7AK4R
Molecule Type:
Small molecule
Molecular Formula:
C8H10IN3
Molecular Weight:
279.1
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TALAZOPARIB TOSYLATE
(2018)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
ORAL
Approved
Breast Neoplasms
TALAZOPARIB TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
02WK9U5NZC
Molecule Type:
Small molecule
Molecular Formula:
C26H22F2N6O4S
Molecular Weight:
552.56
AlogP:
2.63
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ENCORAFENIB
(2018)
Small molecule
Serine/threonine-protein kinase B-raf inhibitor
ORAL
Approved
Melanoma; Neoplasms
ENCORAFENIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
8L7891MRB6
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClFN7O4S
Molecular Weight:
540.02
AlogP:
3.91
PSA:
140.13
HBD:
3.0
HBA:
#RotB:
9.0
Source:
FOSNETUPITANT
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSNETUPITANT
×
Maximum Phase:
4
First Approval:
2018
UNII:
T672P80L2S
Molecule Type:
Small molecule
Molecular Formula:
C31H35F6N4O5P
Molecular Weight:
688.61
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GLASDEGIB MALEATE
(2018)
Small molecule
Smoothened homolog antagonist
ORAL
Approved
Leukemia, Myeloid, Acute
GLASDEGIB MALEATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
TH2EV99S4Z
Molecule Type:
Small molecule
Molecular Formula:
C25H26N6O5
Molecular Weight:
490.52
AlogP:
3.39
PSA:
96.84
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MIGALASTAT HYDROCHLORIDE
(2018)
Small molecule
Alpha-galactosidase A stabiliser
ORAL
Approved
Fabry Disease
MIGALASTAT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
CLY7M0XD20
Molecule Type:
Small molecule
Molecular Formula:
C6H14ClNO4
Molecular Weight:
199.63
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
LUSUTROMBOPAG
(2018)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Hemorrhage; Thrombocytopenia
LUSUTROMBOPAG
×
Maximum Phase:
4
First Approval:
2018
UNII:
6LL5JFU42F
Molecule Type:
Small molecule
Molecular Formula:
C29H32Cl2N2O5S
Molecular Weight:
591.56
AlogP:
8.52
PSA:
97.75
HBD:
2.0
HBA:
#RotB:
13.0
Source:
1
2
…
67
68
69
70
71
72
73
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA